Role in reducing antibiotics prescribingRapid.

Abbott acquires STARLIMS Technologies for $123M Related StoriesOJ Bio at Medica 2015 – Point of Care diagnostics' role in reducing antibiotics prescribingRapid, award winning diagnostic lab tests to be offered at MEDICATransitioning infrared imaging into clinical use: an interview with Dr Matthew BakerAbbott announced today that it has completed its $123 million acquisition of STARLIMS Technology Ltd., a leader in laboratory information management systems http://viagradanmark.org . STARLIMS’s advanced web-based applications help laboratories efficiently store, retrieve and analyze data and are designed for a multitude of laboratory environments operating across a number of scientific, industrial and clinical disciplines.

The patent previously was accepted in New Zealand which was the first country to approve a patent for AbSorbers product. The Europe are highly prioritized marketplaces for AbSorber and the patent approval can be an important milestone in Absorbers intellectual home strategy. Andrew WardLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. KlegermanVaccines – a needle-free potential? An interview with Thomas Johnston and Dr. Anti-endothelial cell antibodies have already been demonstrated to play a key role in causing post-transplantation rejections.